Eye on Ocular Health

Episodes 1-4 of 4

• 

  RestartResume

  Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD

  RestartResume

  Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD

  CME/CE

  Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD

  0.25 credits

  • 

    

    Diana V. Do, MD

  • 

    

    Peter K. Kaiser, MD

  0.25 credits

• 

  RestartResume

  Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits 

  RestartResume

  Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits 

  CME/CE

  Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits 

  0.25 credits

  • 

    

    Jennifer I. Lim, MD, FARVO

  • 

    

    Carl Regillo, MD

  0.25 credits

• 

  RestartResume

  Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

  RestartResume

  Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

  CME/CE

  Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying

  0.25 credits

  • 

    

    Carl Regillo, MD

  • 

    

    Jennifer I. Lim, MD, FARVO

  0.25 credits

• 

  RestartResume

  Extending Treatment Durability With Next-Generation Neovascular AMD Therapies 

  RestartResume

  Extending Treatment Durability With Next-Generation Neovascular AMD Therapies 

  CME/CE

  Extending Treatment Durability With Next-Generation Neovascular AMD Therapies 

  0.50 credits

  • 

    

    Durga Borkar, MD, MMCi

  • 

    

    Diana V. Do, MD

  • 

    

    Peter K. Kaiser, MD

  0.50 credits